Paid Clinical Trials in Hackensack, NJ
As of September 2026, 306 paid clinical trials are recruiting in Hackensack, New Jersey. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Hackensack offers studies at sites including Hackensack University Medical Center for conditions such as Acute Myeloid Leukemia, Advanced Solid Tumor, Breast Cancer, Heart Failure. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in Hackensack
Trials by drug in Hackensack
Filter results
Newly added in Hackensack
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
285 clinical trials
A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal Adenocarcinoma
A Phase 3 Trial to Compare IV BCV Versus IV CDV for Treatment of Adenovirus Infection After Allo-HCT
A Study to Learn About a Clostridioides Difficile Vaccine in People 65 Years of Age and Older
Symbiotic-Lung-20: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Different Anticancer Agents in Advanced Cancers
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
Phase 2/3 Adaptive Study of VX-147 in Adult and Pediatric Participants With APOL1-Mediated Proteinuric Kidney Disease
A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
A Study Evaluating BFB759 in Moderate to Severe Hidradenitis Suppurativa
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016)
A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) (MK-1026-011/BELLWAVE-011)
A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012)
A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Triple-Negative Breast Cancer (MK-2870-011/TroFuse-011)
Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
A Study to Evaluate the Safety and Efficacy of Tacabrutideg (BGB-16673) Compared to Pirtobrutinib in Adults With Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.
Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC
Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)
A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy
MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
A Study of INCB123667 in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
BradycArdia paCemaKer With AV Interval Modulation for Blood prEssure treAtmenT
Efficacy of the COronary SInus Reducer in Patients With Refractory Angina II
A Study to Determine if BHV-7000 is Effective and Safe in Adults With Refractory Focal Onset Epilepsy
A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)
A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM)
A Long-term Study for Participants Previously Treated With Ciltacabtagene Autoleucel
Drug-Eluting Registry: Real-World Treatment of Lesions in the Peripheral Vasculature
Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure
A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103)
A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
A Study of Amivantamab in Participants With Advanced or Metastatic Solid Tumors Including Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small Cell Lung Cancer
A Study to Evaluate XEN1101 as Adjunctive Therapy in Primary Generalized Tonic-Clonic Seizures
A Phase 2 Study of ACR-368 in Endometrial Adenocarcinoma
A Study of Oral Nuvisertib (TP-3654) in Patients With Myelofibrosis
Top Research Study Locations in Hackensack
Researchers run research studies in Hackensack, NJ at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Hackensack University Medical Center | Heart Failure, Advanced Solid Tumor, Neuroblastoma | 126 |
| John Theurer Cancer Center at Hackensack University Medical Center | Acute Myeloid Leukemia, Leukemia, Myeloid, Acute, Breast Cancer | 45 |
| John Theurer Cancer Center | Melanoma, Urothelial Carcinoma, Advanced Non-Small Cell Lung Cancer | 14 |
| Hackensack Meridian Health | Atrial Fibrillation, Breast Cancer, Cardiogenic Shock | 11 |
| John Theurer Cancer Center at Hackensack UMC | Acute Myeloid Leukemia, Advanced Endometrial Carcinoma, Advanced Gastric Carcinoma | 8 |
| John Theurer Cancer Center Hackensack University Medical Center | Advanced Solid Tumor, Advanced Solid Tumors, Chronic Lymphocytic Leukemia | 6 |
| Northeast Regional Epilepsy Group | Epilepsy, Focal Epilepsy, Focal Onset Seizures | 6 |
| Hackensack Medical Center | Myelodysplastic Syndromes, Acute Myeloid Leukemia, Alzheimer Disease | 5 |
| Hackensack Meridian Health (Data collection only) | Diffuse Large B Cell Lymphoma (DLBCL), Follicular Lymphoma, High Grade B Cell Lymphoma | 4 |
| Hackensack Meridian Health - Hackensack University Medical Center | Plasma Cell Myeloma Refractory, Hemophilia, Glycogen Storage Disease Type II | 4 |
| John Theurer Cancer Center, Hackensack University Medical Center | Blood Protein Disorders, Essential Thrombocythemia, Gene Therapy | 3 |
| Ascentage Investigative | CML, CML, Chronic Phase, Chronic Myeloid Leukemia | 2 |
| GSK Investigational Site | HIV Infections, Multiple Myeloma, Newly Diagnosed Multiple Myeloma | 2 |
| HMH Hackensack University Medical Center | Clostridoides Difficile Associated Disease, Stroke, Acute | 2 |
| Hackensack Univeristy Medical Center | Pre-Term, Premature, Respiratory Distress Syndrome in Premature Infant | 2 |
| Hackensack University Medical Center - John Theurer Cancer Center | Endometrial Cancer, Non-squamous EGFR Wt NSCLC, Ovarian Cancer | 2 |
| John Theurer Cancer Center-Hackensack | Locally Advanced Extrapulmonary Neuroendocrine Carcinoma, Locally Advanced Large Cell Neuroendocrine Carcinoma of the Lung, Locally Advanced Merkel Cell Carcinoma | 2 |
| Joseph M. Sanzari Children's Hospital at Hackensack University Medical Center | Low-grade Glioma, BRAF V600 Mutation, High-Grade Glioma (HGG) | 2 |
| Joseph M. Sanzari Children's Hospital | Cerebroside Lipidosis Syndrome, Fabry Disease, Gaucher Disease | 2 |
| NEREG | Focal Epilepsy | 2 |
| Praxis Research Site | Epilepsy, Tonic-Clonic, Focal Onset Seizure, Focal Seizure | 2 |
| Amanda Khoudary | Lung Cancer | 1 |
| Context Investigational Site | Cholangiocarcinoma Advanced, Cholangiocarcinoma Non-resectable, Colorectal Cancer | 1 |
| Exelixis Clinical | Clear Cell Renal Cell Carcinoma (ccRCC), Colorectal Cancer (CRC), Drug-Drug Interaction (DDI) | 1 |
| HMH David Jurist Research Building | Clostridoides Difficile Associated Disease | 1 |
Active & Upcoming Studies in Hackensack (2026)
Recruiting trials in Hackensack grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (171 active studies)
- Phase 2b of RAPA-201 Cell Therapy in Post-PD-(L)-1 Melanoma · Phase 2 · Rapa Therapeutics LLC
- A Combination Therapy Strategy to Prevent Anti-PD-1 Therapy Resistance in Metastatic Ovarian Cancer Patients · Phase 2 · Georgetown University
Cardiovascular (14 active studies)
- INitiation and Titration of Guideline Directed Medical TheRApy in HearT Failure Cardiogenic Shock With ImpElla 5.5 for Cardiac Recovery · Abiomed Inc.
- A Prospective, Randomized Multicenter Clinical Trial of the TricValve® Transcatheter Bicaval Valve System in Subjects With Severe Tricuspid Regurgitation. · P+F Products + Features USA Inc.
Neurology & pain (13 active studies)
- Battlefield Acupressure for Acute Back Pain Management in the Emergency Department · Hackensack Meridian Health
- Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Focal Seizures FOCUS-1 · Phase 3 · Rapport Therapeutics Inc.
Pediatric (5 active studies)
- ED Medicaid Support · Hackensack Meridian Health
- Utilization of Lung Ultrasound Score in Decision for Minimally Invasive Surfactant Administration · Hackensack Meridian Health
Diabetes & metabolic (3 active studies)
- Efficacy, Safety, and Pharmacokinetics of Tirzepatide (LY3298176) Once Weekly Versus Placebo in Pediatric Participants 6 to Less Than 12 Years of Age Who Have Obesity (ADVANCE-SURMOUNT-KIDS) · Phase 3 · Eli Lilly and Company
- A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040) · Phase 3 · Eli Lilly and Company
HIV / STI (1 active study)
- A Phase 2b Study Evaluating Oral VH4524184 Regimens in Treatment Naïve Persons With HIV-1 (INNOVATE Study) · Phase 2 · ViiV Healthcare
Mental health & behavior (1 active study)
- OBWELL: Innovative Psychotherapeutic Intervention to Treat Postpartum Depression · Hackensack Meridian Health
Common conditions studied in Hackensack
- Acute Myeloid Leukemia (10 active studies)
- Advanced Solid Tumor (9 active studies)
- Breast Cancer (9 active studies)
- Heart Failure (8 active studies)
- Multiple Myeloma (8 active studies)
- Ovarian Cancer (8 active studies)
Leading research sponsors in Hackensack
- Merck Sharp & Dohme LLC
- Children's Oncology Group
- Hackensack Meridian Health
- AstraZeneca
- National Cancer Institute (NCI)
Frequently asked questions
How many paid clinical trials are currently recruiting in Hackensack?
There are approximately 306 recruiting clinical trials in Hackensack, New Jersey listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Hackensack pay participants?
Most recruiting trials in Hackensack compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Hackensack?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Hackensack?
The most common conditions under active study in Hackensack include Acute Myeloid Leukemia (10), Advanced Solid Tumor (9), Breast Cancer (9), Heart Failure (8), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Hackensack?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Hackensack on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Hackensack?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Hackensack?
Recruiting research sites in Hackensack include Hackensack University Medical Center, John Theurer Cancer Center at Hackensack University Medical Center, John Theurer Cancer Center, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Hackensack right now?
The largest active categories in Hackensack are Cancer & tumors (171), Cardiovascular (14), Neurology & pain (13). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.